Cargando…
Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study
BACKGROUND AND METHODS: An efficacy population of 245 patients with vertigo of peripheral vestibular origin was recruited in Romania as part of a 3-month multinational, post-marketing surveillance study of open-label betahistine 48 mg/day (OSVaLD). Endpoints were changes in the Dizziness Handicap In...
Autores principales: | Băjenaru, Ovidiu, Roceanu, Adina Maria, Albu, Silviu, Zainea, Viorel, Pascu, Alexandru, Georgescu, Mădălina Gabriela, Cozma, Sebastian, Mărceanu, Luigi, Mureşanu, Dafin Fior |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260659/ https://www.ncbi.nlm.nih.gov/pubmed/25506241 http://dx.doi.org/10.2147/IJGM.S71015 |
Ejemplares similares
-
Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo
por: Morozova, Svetlana Vyacheslavovna, et al.
Publicado: (2015) -
Vestibular regeneration – experimental models and clinical implications
por: Albu, Silviu, et al.
Publicado: (2012) -
Romanian registry for interventional treatment in acute stroke: a hope for secondary prevention through medication adherence improvement
por: Tiu, Cristina, et al.
Publicado: (2023) -
Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department
por: Davidescu, Eugenia Irene, et al.
Publicado: (2021) -
Lessons from Neurotrauma Treatment Simulation Center (NTSC) – The neurosurgeon's perspective
por: Padurean, Vlad Adrian, et al.
Publicado: (2022)